CluePoints Unveils Innovative Medical & Safety Review Application

CluePoints

KING OF PRUSSIA, PA — CluePoints has announced the launch of its latest application, Medical & Safety Review (MSR), designed to revolutionize the analysis of medical study data. MSR offers a streamlined approach to data review, featuring user-friendly dashboards and comprehensive data manipulation tools. This application enhances medical oversight and patient safety by providing full transparency over data history, while also simplifying the process for medical reviewers.

MSR is specifically crafted to replace the manual analysis of patient outcomes with an efficient and accurate system. It boasts a comprehensive library of standard visualizations and the capability to reuse dashboards across different studies. This feature allows for the easy identification of outlying values and trends, thereby improving communication and decision-making in clinical trials.

The application also includes automated checks to reduce human error, integrated workflows for enhanced collaboration, and comprehensive change tracking to ensure accountability. These features collectively result in faster decision-making and ensure adherence to regulatory compliance through rule-based detection and user assignments.

Andy Cooper, CEO of CluePoints, expressed enthusiasm about the new development, stating, “We are thrilled to announce the launch of Medical & Safety Review to our growing product offerings. MSR ensures a more streamlined review process while prioritizing patient safety at every step and empowers medical teams to swiftly identify outliers, track data changes, and improve communication.”

This launch marks a significant addition to CluePoints’ platform, complementing existing tools like Risk-Based Quality Management and the Site Profile & Oversight Tool, and further supporting the optimization of clinical trials.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.